Torrent Pharmaceuticals has raised Rs 200 crore through Commercial Papers (CPs) on December 26, 2024. Maturity of the said Commercial Papers will be on March 26, 2025. The company has issued CPs at coupon/ interest/ discount rate of 7.10% per annum.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.